← Eichor
Condition: Pediatric Malignant Solid Tumor Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pediatric Malignant Solid Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · 6 location(s) · Nationwide Children's Hospital · NCT05135975Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors
Phase 1 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06047977Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Phase 1/Phase 2 · 2 location(s) · St. Jude Children's Research Hospital · NCT05468359Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pe
Phase 1 · 7 location(s) · National Cancer Institute (NCI) · NCT05372640Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Pati
NA · 2 location(s) · M.D. Anderson Cancer Center · NCT04678427Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
Phase 1 · 1 location(s) · Kyushu University · NCT05608148A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBE
Phase 1/Phase 2 · 63 location(s) · Merck Sharp & Dohme LLC · NCT06941272A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepat
Phase 1 · 5 location(s) · Chiome Bioscience Inc. · NCT06636435Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1 · 2 location(s) · National Cancer Institute (NCI) · NCT04222413Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
Phase N/A · 3 location(s) · National Cancer Institute (NCI) · NCT03739827A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participan
Phase 1/Phase 2 · 7 location(s) · Merck Sharp & Dohme LLC · NCT07302347Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT07148050AIMS Cancer Outcomes Study
Phase N/A · 1 location(s) · Advanced Integrative Medical Science Institute · NCT04495790Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tu
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04715191A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Phase 2 · 16 location(s) · Memorial Sloan Kettering Cancer Center · NCT05985161Liquid Biopsies in Pediatric Solid Tumors
Phase N/A · 1 location(s) · Children's Hospital Los Angeles · NCT05068583B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT04897321A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBE
Phase 1/Phase 2 · 17 location(s) · Merck Sharp & Dohme LLC · NCT07630974An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Phase 3 · 1 location(s) · Mayo Clinic · NCT06915727Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Laminar Pharmaceuticals · NCT04299191
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.